IV Hydration Therapy Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Immune Booster, Energy Booster, Skin Care, Others), By Component (Emergency Healthcare, Routine Healthcare), By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The global IV Hydration Therapy Market is anticipated to expand significantly, growing from USD 2.99 Billion in 2025 to USD 4.72 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.91%. This therapy delivers fluids, electrolytes, vitamins, and medications directly into the bloodstream, offering quick solutions for dehydration, nutrient deficiencies, and acute recovery. Its growth is largely fueled by the increasing incidence of chronic health conditions and a shift in consumer focus towards preventive healthcare and rapid wellness interventions. Beyond traditional medical facilities, the market's reach has been extended through its adoption in wellness tourism and spas. This broader integration is evidenced by the International Spa Association's 2025 finding that 12% of spas provided medically supervised services, highlighting a rising consumer demand for clinical treatments within holistic wellness settings.
Market Driver
A significant driver for the Global IV Hydration Therapy Market is the increasing consumer inclination towards preventive healthcare and overall wellness. IV therapy is now perceived less as a treatment for acute ailments and more as a regular enhancement for vitality and immune support, with individuals seeking nutrient infusions to boost physical performance, expedite athletic recovery, and proactively maintain their health. This trend is clearly demonstrated by the rapid growth of wellness franchise networks, exemplified by Restore Hyper Wellness, which topped its category in January 2025 with an impressive 151% three-year growth rate, as reported by Entrepreneur, affirming the market's successful transition towards holistic health offerings. The expansion is further fueled by the swift rise of mobile IV services and concierge medicine, which effectively eliminate geographical and logistical obstacles to care. Providers are now utilizing digital platforms and decentralized models to deliver medical-grade therapies directly to clients' homes, offices, and hotels, attracting a wider audience seeking convenience. This operational scalability is highlighted by strategic collaborations, such as Hydreight Technologies' January 2025 partnership with The DRIPBaR to extend direct-to-consumer services across 450 franchise locations. The cumulative increase in these accessible care points is substantially enhancing market penetration, with the American Med Spa Association projecting 11,553 medical spa facilities in the United States by 2025, underscoring the vital role of mobile and franchise integrations in expanding market reach.
Market Challenge
The Global IV Hydration Therapy Market faces substantial constraints due to stringent regulatory compliance and supervision requirements. As the industry expands into diverse non-hospital settings, including medical spas and mobile units, state regulatory bodies are imposing increasingly rigorous protocols on aspects such as sterile compounding and the 'corporate practice of medicine.' This escalating scrutiny establishes a complex and expensive operational landscape, where inconsistent or unclear state-by-state licensing laws act as considerable barriers to entry. The mandates for continuous physician oversight and adherence to pharmacy board standards necessitate significant legal and personnel expenditures for providers, consequently diminishing profit margins and deterring investment in new operational sites. This regulatory impediment is exacerbated by the industry's largely fragmented structure, predominantly composed of small, independent operators rather than larger, well-resourced health systems. The American Med Spa Association reported in late 2024 that 81% of medical spas operated as single-location facilities. This reliance on smaller enterprises means that the majority of market participants often lack the institutional capacity to effectively manage evolving compliance mandates, leading to a disproportionate financial and administrative burden. This burden, in turn, is hindering growth and limiting the scalability of what is otherwise the market's most dynamic and innovative segment.
Market Trends
A notable trend redefining market accessibility is the convergence of IV hydration therapy with luxury hospitality and medical tourism, wherein providers are integrating intravenous treatments into premium travel experiences. High-end resorts and airlines are increasingly offering IV hydration as a luxurious amenity to alleviate jet lag and fatigue, thus positioning the service as a crucial part of the travel itinerary rather than solely a medical requirement. An example of this integration is the strategic partnership formed in February 2025 between beOnd Airlines and The Elixir Clinic, allowing the carrier to offer exclusive vitamin infusions as an optional add-on for passengers, thereby directly blending clinical wellness with upscale leisure travel. Concurrently, there is a significant surge in demand for NAD+ and anti-aging cocktails, which is redirecting consumer interest from immediate recovery towards long-term cellular longevity and biohacking. This trend is marked by the growing popularity of nicotinamide adenine dinucleotide (NAD+) infusions, sought for their perceived ability to restore mitochondrial function and combat age-related decline. The commercial strength of this segment is underscored by the financial performance of major ingredient suppliers, with ChromaDex reporting a 19% increase in annual sales to $99.6 million in March 2025, a growth trajectory that highlights the expanding consumer desire for specialized metabolic and anti-aging formulations.
Key Market Players
* Core IV Therapy, LLC
* Cryojuvenate UK Ltd
* B. Braun SE
* Pfizer, Inc.
* JW Life Science Co. Ltd.
* Amanta Healthcare Ltd.
* Vifor Pharma Management Ltd
* Otsuka Pharmaceutical Co., Ltd.
* Baxter International Inc.
* ICU Medical, Inc.
Report Scope
In this report, the Global IV Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# IV Hydration Therapy Market, By Service
* Immune Booster
* Energy Booster
* Skin Care
* Others
# IV Hydration Therapy Market, By Component
* Emergency Healthcare
* Routine Healthcare
# IV Hydration Therapy Market, By End Users
* Hospitals & Clinics
* Wellness Centers & Spa
* Home Healthcare
* Others
# IV Hydration Therapy Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global IV Hydration Therapy Market.
Available Customizations:
Global IV Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global IV Hydration Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America IV Hydration Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Component
6.2.3. By End Users
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States IV Hydration Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Component
6.3.1.2.3. By End Users
6.3.2. Canada IV Hydration Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Component
6.3.2.2.3. By End Users
6.3.3. Mexico IV Hydration Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Component
6.3.3.2.3. By End Users
7. Europe IV Hydration Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Component
7.2.3. By End Users
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany IV Hydration Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Component
7.3.1.2.3. By End Users
7.3.2. France IV Hydration Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Component
7.3.2.2.3. By End Users
7.3.3. United Kingdom IV Hydration Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Component
7.3.3.2.3. By End Users
7.3.4. Italy IV Hydration Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Component
7.3.4.2.3. By End Users
7.3.5. Spain IV Hydration Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Component
7.3.5.2.3. By End Users
8. Asia Pacific IV Hydration Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Component
8.2.3. By End Users
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China IV Hydration Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Component
8.3.1.2.3. By End Users
8.3.2. India IV Hydration Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Component
8.3.2.2.3. By End Users
8.3.3. Japan IV Hydration Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Component
8.3.3.2.3. By End Users
8.3.4. South Korea IV Hydration Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Component
8.3.4.2.3. By End Users
8.3.5. Australia IV Hydration Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Component
8.3.5.2.3. By End Users
9. Middle East & Africa IV Hydration Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Component
9.2.3. By End Users
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia IV Hydration Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Component
9.3.1.2.3. By End Users
9.3.2. UAE IV Hydration Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Component
9.3.2.2.3. By End Users
9.3.3. South Africa IV Hydration Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Component
9.3.3.2.3. By End Users
10. South America IV Hydration Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Component
10.2.3. By End Users
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil IV Hydration Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Component
10.3.1.2.3. By End Users
10.3.2. Colombia IV Hydration Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Component
10.3.2.2.3. By End Users
10.3.3. Argentina IV Hydration Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Component
10.3.3.2.3. By End Users
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global IV Hydration Therapy Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Core IV Therapy, LLC
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Cryojuvenate UK Ltd
15.3. B. Braun SE
15.4. Pfizer, Inc.
15.5. JW Life Science Co. Ltd.
15.6. Amanta Healthcare Ltd.
15.7. Vifor Pharma Management Ltd
15.8. Otsuka Pharmaceutical Co., Ltd.
15.9. Baxter International Inc.
15.10. ICU Medical, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們